Ohidul Alam | Drug Safety and Risk Management | Best Researcher Award

Ohidul Alam | Drug Safety and Risk Management | Best Researcher Award

Dr. Ohidul Alam, Jiangsu University, China

Dr. Ohidul Alam is an Environmental Engineer specializing in heavy metals, microplastics, and waste management. He earned his Ph.D. from East China University of Science and Technology (2021) and currently works as a Postdoctoral Fellow at Jiangsu University, China. 🔬 His research focuses on eco-friendly wastewater treatment, hazardous waste recycling, and environmental pollution assessment. With expertise in advanced analytical techniques (ICP-MS, XRF) and life cycle assessment, he has published extensively in top environmental journals. 🧪 Passionate about sustainable development and climate change, Dr. Alam actively contributes to environmental awareness through academic writing and collaborative projects worldwide.

Publication Profile

Google Scholar

Education

Dr. Ohidul Alam has a rich academic background in environmental sciences and engineering 🌱. He earned his Ph.D. in Environmental Engineering from the East China University of Science and Technology, Shanghai 🇨🇳 (2016–2021), preceded by an M.Eng. from the UNEP-Tongji Institute for Sustainable Development, Tongji University (2014–2016) 🧪. Earlier, he completed his M.S. and B.Sc. (Hons.) in Environmental Science from the University of Chittagong, Bangladesh 🇧🇩. His foundational education includes HSC from Government City College and SSC from Shilkhali High School in Cox’s Bazar. 🏫 This strong educational journey laid the groundwork for his impactful environmental research 🌏.

Experience

🧑‍🔬 Dr. Ohidul Alam has built an impressive career in environmental research and sustainability 🌿. Currently, he serves as a Post-doctoral Research Fellow at Jiangsu University, China 🇨🇳. His prior roles include Environmental Officer at SEP-IDF and Consultant at DM WATCH and SETS 🏢. His expertise spans hazardous waste, microplastics, climate change, and wastewater treatment 💧. With experience in academic research, project implementation, statistical analysis, and lab techniques like ICP-MS and XRD 🔬, he also writes on environmental topics for leading dailies 📰. Dr. Alam is fluent in Bangla and English and skilled in SPSS and OriginPro 💻.

Awards

Dr. Ohidul Alam has earned several prestigious awards and scholarships for his outstanding academic and research achievements 🌟. He received the Chinese Scholarship Council (CSC) and Marine Scholarship of China (MSC) in 2014 🇨🇳. In 2015, he was honored with Tongji University President Scholarship (2nd prize) 🥈, followed by the Shanghai Municipal Government Scholarship in 2016 🎓. His paper won first prize at the International Student Conference on Environment and Sustainability in 2017 📄🌍. In 2018, he received the ECUST Comprehensive Scholarship (1st prize) for academic excellence and remarkable research contributions .

Research Focus

Dr. Ohidul Alam’s research primarily focuses on environmental science, with a strong emphasis on waste management, environmental pollution, and sustainability. His work explores diverse aspects such as municipal solid waste management, plastic pollution, heavy metals contamination, and eco-friendly remediation technologies. He contributes significantly to understanding the environmental impacts of plastic bags, healthcare waste management, and green business opportunities in Bangladesh. Additionally, Dr. Alam’s recent interests include adsorption techniques for water purification and life cycle assessments. His interdisciplinary research combines chemistry, engineering, and public health to foster a more sustainable and cleaner environment.

Publication Top Notes

An in-depth review on municipal solid waste management, treatment and disposal in Bangladesh

Characteristics of plastic bags and their potential environmental hazards

Determination of the selected heavy metal and metalloid contents in various types of plastic bags

Heavy metals dispersion during thermal treatment of plastic bags and its recovery

Remediation of heavy metals polluted soil environment: A critical review on biological approaches

A preliminary life cycle assessment on healthcare waste management in Chittagong City, Bangladesh

Application of environmental ethics for sustainable development and conservation of Saint Martin s Island in Bangladesh

A deeper look into the inner factors associated to healthcare waste management in Chittagong–the commercial capital of Bangladesh

An investigation into the green business opportunity for the new entrepreneurs in the municipal wastes recycling sector of Bangladesh

Heavy metals detection and removal from contaminated water: A critical review of adsorption methodsA critical review on advances in remediation of toxic heavy metals contaminated solids by chemical processes

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Collaboration, Thailand

Dr. Anchalee Avihingsanon, MD, PhD 🩺🔬 is a distinguished infectious disease specialist with over 20 years of expertise in HIV/AIDS, tuberculosis, and viral hepatitis research. She leads the HIV-NAT clinical research program at the Thai Red Cross AIDS and Infectious Disease Research Centre in Bangkok 🇹🇭 and serves as Clinical Research Site Leader for ACTG. Dr. Avihingsanon actively shapes national health policies in Thailand and contributes to WHO guideline development 🌏. Her international research spans clinical trials addressing HIV, TB, and emerging infections. She has earned numerous awards for her impactful work in resource-limited settings.

Publication Profile

Orcid

Education

Dr. Anchalee Avihingsanon completed her medical degree (MD) at Khon Kaen University, Thailand, from 1986 to 1992. She then specialized in Internal Medicine at Chulalongkorn University, Bangkok, during 1994-1996, followed by a focus on Infectious Disease from 1998 to 1999 at the same institution. Dr. Avihingsanon advanced her expertise as a research fellow in Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, USA, from 2000 to 2002. She earned her PhD in HIV and Coinfection at Amsterdam University, The Netherlands, between 2011 and 2013.

Experience

Dr. Anchalee Avihingsanon has been actively involved in numerous professional roles since 1999. She currently serves as the ACTG Regional Representative for Asia and is a key member of several WHO advisory groups on HIV, viral hepatitis, and STIs. She is also an infectious disease expert on Bangkok’s Essential Medicine Committee and contributes to national efforts on AIDS, TB, and hepatitis. Dr. Avihingsanon participates in multiple research and guideline committees, including the Thai Ministry of Public Health and international scientific groups. She holds memberships in prestigious organizations like the International AIDS Society and the Royal College of Physicians.

Awards

Dr. Anchalee Avihingsanon has received numerous honors throughout her career. In 2016, she successfully passed the US-FDA inspection for key studies. She was awarded the Australia-APEC Women in Research Fellowship in 2015 and received the prestigious NUFFIC PhD grant from the Netherlands Embassy during 2011-2013. Dr. Avihingsanon earned scholarships to attend global workshops and conferences, including the European AIDS Conference and International AIDS Society from 2007 to 2022. Early in her career, she was recognized as Best Doctor at Samutsakorn Hospital in 1998 and served as chief resident at King Chulalongkorn Memorial Hospital in 1997.

Research Focus

Dr. Anchalee Avihingsanon is a distinguished researcher specializing in HIV and Hepatitis C co-infections, with a strong focus on antiretroviral therapy optimization, pharmacokinetics, and treatment outcomes. Her work includes evaluating minimal monitoring HCV treatments, assessing drug interactions in people living with HIV, and improving health-related quality of life for patients. She also investigates malnutrition, sarcopenia risks in elderly HIV patients, and liver fibrosis progression using advanced diagnostics. Anchalee’s contributions significantly impact infectious disease management, particularly in Asian populations, aiming to enhance therapy safety, efficacy, and accessibility.

Publication Top Notes

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life
The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
The Risk of Malnutrition and Sarcopenia in Elderly People Living with HIV during the COVID-19 Pandemic
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
The 25th Bangkok International Symposium on HIV Medicine
Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis
Conference Proceedings from the Virtual 24th Bangkok International Symposium on HIV Medicine
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial